comprehensive -WSS

comprehensive

author：focus 2025-09-03 05:36:16 - browse：1513

Aduhelm package — Jessica Rinaldi/The Boston Globe

Biogen is giving up its ownership of Aduhelm, the Alzheimer’s disease treatment whose 2021 approval led to scrutiny and outrage, turning the page on a tempestuous chapter in the company’s long history.

Neurimmune, the Swiss company that invented Aduhelm, will regain full rights to the intravenous medicine, Biogen said Wednesday. Biogen will also terminate an ongoing clinical trial meant to prove the treatment’s benefits for patients in the early stages of Alzheimer’s.

“When searching for new medicines, one breakthrough can be the foundation that triggers future medicines to be developed,” Biogen CEO Christopher Viehbacher said in a statement. “Aduhelm was that groundbreaking discovery that paved the way for a new class of drugs and reinvigorated investments in the field.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

WSS

Hospitals warn Medicare's drug payment fix is ‘unlawful’

'Reaching a detente': STAT's Helen Branswell on covering Covid

CDC recommends rationing of RSV shot due to shortages

Celebrate National Dole Whip Day for 3 days this week at Disney

Celebrate National Dole Whip Day for 3 days this week at Disney

Resistance to cancer drugs: A new genetic explanation

explore

comprehensive

focus

The cancer drug shortage isn’t new — and neither are the solutions

Testing for cancer recurrence creates a new limbo for patients

United colonoscopy coverage change 'may cost lives,' doctors say

'Reaching a detente': STAT's Helen Branswell on covering Covid

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CDC recommends rationing of RSV shot due to shortages

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Norman Reedus' Daryl Dixon

Dobbs anniversary: the lost opportunity of abortion as health care

Why some people catch Covid but never get sick

hotspot

Emergency medicine has repudiated 'excited delirium.' Now what?

Medtronic CEO on promising devices for diabetes, hypertension

Paying for Covid pills will soon shift to insurers

Biden's order seeks to regulate AI risk without stifling innovation

Biden's order seeks to regulate AI risk without stifling innovation

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

explore

Wikipedia

focus

hotspot